Slow, steady pressure over 5 to 10 seconds distributes the medication evenly and comfortably
20% InBody DXA Tirzepatide Tirzepatide GIP GLP-1 Mounjaro 2.5mg 2.5mg 15mg Mounjaro Zepbound 0 60 1 5 72 20% 30-35% Rybelsus Rybelsus 14mg 200 30 30 50mg15 15% 50mg 14mg 7mg 30 GLP-1 RA DPP4-i GLP-1 RA MEN2 calcitonin Liraglutide Saxenda 18mg/3mL 0.6mg 1.2mg 3.0mg 2025 1 BMI 30 BMI 27 InBody BMI DXA BMI 56 64% 5% 33% 10% 5-10% 3mg 3300-4000 20-24 3mg 3 5% 7 0.6mg x 7 = 4.2mg 1.2mg x 7 = 8.4mg 1.8mg x 7 = 12.6mg 2.4mg x 7 = 16.8mg 3mg x 7 = 21mg 18mg Victoza 3mg 1.8mg Dulaglutide Trulicity 0.75-1.5mg 4.5mg 3 Semaglutide Wegovy 0.25mg 2.4mg 2.4mg 14mg 15% Ozempic 0.25mg 1mg 1.7-2.4mg Kwikpen
Pregnancy and lactation safety has not been systematically studied, and as with most cosmetic and research compounds lacking definitive pregnancy safety data, conservative practice typically suggests avoiding use during pregnancy unless clearly needed, though the natural occurrence of GHK-Cu in the body and minimal systemic absorption from topical use suggest risk is likely to be low
Brighten the skin, reduce blemishes, freckles, wrinkles, reduce acne and, most importantly, have properties to help protect cells from UV damage
More discipline will prevent regain. Rebound is biological, not behavioral
10.1210/endo.140.1.6417 119
